Details of the Drug
General Information of Drug (ID: DMZHDFM)
Drug Name |
6,7-dichloro-1H-indole-2,3-dione
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
6,7-dichloro-1H-indole-2,3-dione; 18711-12-1; 6,7-Dichloroindoline-2,3-dione; 1H-Indole-2,3-dione,6,7-dichloro-; 6,7-dichloro-2,3-dihydro-1H-indole-2,3-dione; 6,7-dichlorisatin; 6,7-dichloroisatin; AC1Q3HQA; Isatin-based compound, 54; SCHEMBL1248801; CHEMBL222292; CTK4D9416; BDBM22834; DTXSID30588487; MolPort-004-304-808; XTXIILHWOQZVAQ-UHFFFAOYSA-N; STL381782; ZINC14979616; AKOS000139553; MCULE-1304306967; 1H-Indole-2,3-dione, 6,7-dichloro-; AJ-65537; KB-335070; FT-0620847; EN300-36024; Y-0718
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 216.02 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 2 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 0 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 2 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||